|
Accuracy of profiling of circulating tumor DNA for CRC MRD and monitoring using NGS technology equipped with concatemer-based error correction. |
| |
|
Employment - Life Science Pharmaceuticals |
Stock and Other Ownership Interests - Life Science Pharmaceuticals |
| |
|
Employment - Life Science Pharmaceuticals |
Stock and Other Ownership Interests - Life Science Pharmaceuticals |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
Employment - Life Science Pharmaceuticals |
Stock and Other Ownership Interests - Life Science Pharmaceuticals |
Research Funding - Life Science Pharmaceuticals |
| |
|
Employment - Life Science Pharmaceuticals |
Research Funding - Life Science Pharmaceuticals |
| |
|
Employment - Life Science Pharmaceuticals |
Research Funding - Life Science Pharmaceuticals |
| |
|
Employment - Life Science Pharmaceuticals |
| |
|
Employment - Life Science Pharmaceuticals |
| |
|
No Relationships to Disclose |
| |
|
Employment - Life Science Pharmaceuticals |
Stock and Other Ownership Interests - Life Science Pharmaceuticals |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
Employment - Life Science Pharmaceuticals |
Leadership - Life Science Pharmaceuticals |
Stock and Other Ownership Interests - Life Science Pharmaceuticals |
| |
|
Consulting or Advisory Role - Life Science Pharmaceuticals |
| |
|
Employment - Life Science Pharmaceuticals |
Leadership - Life Science Pharmaceuticals |
Stock and Other Ownership Interests - Life Science Pharmaceuticals |